Skip to main content
. 2019 Feb;25(2):282–289. doi: 10.3201/eid2502.180732

Table 3. Performance of rapid diagnostic testing and microscopic examination in establishing malaria diagnosis in 453 febrile patients, using PCR as reference standard, Atar, northern Mauritania, 2015–2016*.

Performance % (95% CI)†
Rapid diagnostic test
Microscopic examination
Pv Pf Pv–Pf Pv Pf Pv–Pf
Sensitivity 63.3 (55.3–70.8) 28.6 (15.7–44.6) 66.0 (58.2–73.3) 82.9 (76.1–88.4) 4.8 (0.6–16.2) 91.4 (85.9–95.2)
Specificity 99.3 (97.6–99.9) 99.0 (97.5–99.7) 99.7 (98.1–99.9) 96.9 (94.3–98.6) 99.5 (98.3–99.9) 97.9 (95.6–99.2)
PPV 98.0 (92.6–99.5) 75.0 (50.3–89.9) 99.1 (93.8–99.9) 93.6 (88.4–96.5) 50.0 (12.6–87.4) 96.1 (91.8–98.2)
NPV 83.5 (80.4–86.1) 93.1 (91.8–94.3) 84.1 (81.0–86.7) 91.4 (88.2–93.7) 91.1 (90.5–91.6) 95.3 (92.5–97.1)
Accuracy 86.8 (83.3–89.7) 92.5 (89.7–94.7) 87.6 (84.2–90.5) 92.1 (89.2–94.4) 90.7 (87.7–93.2) 95.6 (93.3–97.3)

*NPV, negative predictive value; Pf, pure P. falciparum plus mixed P. falciparum–P. vivax; PPV, positive predictive value; Pv, pure P. vivax plus mixed P. falciparum–P. vivax; Pv–Pf, pure P. vivax plus pure P. falciparum plus mixed P. falciparum–P. vivax.
†Percentages of PCR-positive patients (i.e., the percentage of positives for different Plasmodium spp. among included patients [n = 435]), were as follows: 34.9% (95% CI 30.5%–39.5%) for pure P. vivax; 9.3% (95% CI 6.8%–12.3%) for pure P. falciparum; and 35.8% (95% CI 31.3%–40.4%) for P. vivax–P. falciparum mixed infections. PCR showed that none of the samples had P. ovale or P. malariae.